UMIN-CTR History
Name： UMIN ID：
| Unique ID issued by UMIN | UMIN000034225 |
|---|---|
| Receipt number | R000039017 |
| Scientific Title | Olanzapine versus Aprepitant in the triplet regimen for preventing highly emetogenic chemotherapy-induced nausea and vomiting: a double blind, non-inferiority, randomized phase 3 trial |
| Date of disclosure of the study information | 2018/09/21 |
| Last modified on | 2020/09/20 10:14:06 |
| No. | Disposal | Last modified on | Item of update | |
|---|---|---|---|---|
| 1 | Insert | 2018/09/20 22:04:47 | ||
| 2 | Update | 2018/09/21 17:39:59 | Date of disclosure of the study information |
|
| 3 | Update | 2019/03/22 21:41:23 | Recruitment status Date of IRB Anticipated trial start date Last follow-up date |
|
| 4 | Update | 2019/10/01 00:27:46 | Classification by specialty Narrative objectives1 |
|
| 5 | Update | 2020/09/20 10:12:59 | Last follow-up date |
|
| 6 | Update | 2020/09/20 10:14:06 | Classification by specialty |
